Clinical trial strategy was developed through research on a gene associated with treatment-resistant prostate cancer
Findings from the prospective analysis and implications for diagnosing, preventing lethal prostate cancer
How inhibiting the H6PD protein may reverse drug resistance
Cleveland Clinic researchers explore enterprise-wide testing registry to investigate
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Cleveland Clinic-developed test identifies variant of HSD3B1 gene
Cleveland Clinic-led study lays groundwork for more personalized treatments
What's driving tumor progression is the key, says Nima Sharifi, MD
Research has clear implications for future of prostate cancer imaging
DoD grants support biomarker investigations, CRISPR research
Milestone studies advance understanding and treatment of prostate cancer